Clinical Trial Update: Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating targeted decolonization of persistent Staphylococcus aureus carriers in hemodialysis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Hemodialysis Patients | Phase 4 | Status: TERMINATED